Crossmark

The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies

Crossref DOI link: https://doi.org/10.1007/s13311-022-01221-y

Published Print: 2022-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Querol, Luis A.

Hartung, Hans-Peter

Lewis, Richard A.

van Doorn, Pieter A.

Hammond, Timothy R.

Atassi, Nazem

Alonso-Alonso, Miguel https://orcid.org/0000-0003-3372-9933
Dalakas, Marinos C. https://orcid.org/0000-0001-7070-1134
Funding

Funding for this research was provided by:

Sanofi
License Information

Text and Data Mining valid from 2022-04-01

Text and Data Mining valid from 2022-04-01

Version of Record valid from 2022-04-04
More Information

This article is maintained by: Elsevier

Article Title: The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-022-01221-y

Content Type: article

Copyright: Copyright © 2022 The authors. Published by Elsevier B.V. All rights reserved.